全世界の ワクチン 同盟 GAVI hopes India will 再開する 輸出（する）s this ４半期/4分の1
By Krishna N. Das and Neha Arora
NEW DELHI, July 7 (Reuters) - The GAVI ワクチン 同盟 hopes the Serum 学校／設ける of India (SII) will 再開する 輸出（する）s of the AstraZeneca COVID-19 ワクチン from this ４半期/4分の1, it told Reuters, earlier than the 会社／堅い's 予測（する） of the end of this year.
GAVI co-leads the COVAX 施設 for equitable 配当 of COVID-19 発射s around the world. COVAX 苦しむd a big 揺さぶる in April when big ワクチン 生産者 India stopped all overseas 出荷／船積みs to 会合，会う 地元の 需要・要求する as 感染s rose 劇的な.
India's coronavirus 危機 has now 緩和するd and 生産（高） of the AstraZeneca 麻薬 at SII, the world's biggest ワクチン 製造者, has also jumped, but so has 国内の 需要・要求する.
"We remain 希望に満ちた that SII 配達／演説／出産s will 再開する in the third ４半期/4分の1, however, this cannot be 確認するd at this 行う／開催する／段階," a GAVI spokesperson said in an e-mail late on Tuesday.
"In the 合間, COVAX has been 積極性 に引き続いて through on its 戦略 of diversifying its 大臣の地位, 安全な・保証するing over a billion 付加 doses in the past month alone either through direct 調達s or through dose 株ing."
An Indian 政府 source said a 決定／判定勝ち（する） on 輸出（する）s might be made next month when the country's COVID-19 ワクチン 生産（高） is 推定する／予想するd to rise その上の.
SII did not すぐに 答える／応じる to a request for comment. A source の近くに to SII said the company was 焦点（を合わせる）d on 供給（する）ing to India for now. It said https://twitter.com/SerumInstIndia/status/1394652001573629958/photo/1 in May that it hoped to "start 配達するing to COVAX and other countries by the end of this year".
India's foreign 省 did not すぐに 答える／応じる to queries from Reuters.
Bangladesh's health 大臣 told reporters on Tuesday that SII could 再開する 供給（する）s to it from August. The country is 苦しむing from a resurgence in 感染s and has received only 7 million doses out of 30 million it has ordered from the company.
India has so far 広告 大臣d https://dashboard.cowin.gov.in 358.1 million ワクチン doses - the most in the world after 中国 - giving at least one dose to 31% of its 概算の adult 全住民 of 944 million. (報告（する）／憶測ing by Krishna N. Das; Editing by Raju Gopalakrishnan and Kim Coghill)
